Cataract surgery with combined versus deferred intravitreal dexamethasone implant for diabetic macular edema: long-term outcomes from a real-world setting
ConclusionsDEX implant performed at the time of surgery achieved the same long-term functional and anatomical outcomes compared to a 1-month injection deferral in treating eyes with pre-existing DME that should undergo cataract extraction.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
More News: Cataract Removal | Cataracts | Dexamethasone | Diabetes | Endocrinology | Eye Implants | Eyes | Vitamin A